In an Ang II-dependent malignant hypertension model using Cyp1a1-Ren-2 transgenic rats, blocking GPR75 with AAA effectively reversed I3C-induced malignant hypertension, which is associated with reduced Ang II levels in plasma and kidneys [66]. Here, CYP1A1 is linked to malignant hypertension.